- 
                
                
                
the position is filled. Application deadline is 12/1/2025 or until filled. Please complete application on-line at *** or send application materials and direct questions to: Tammy Wilgenbusch, PhD Training
 - 
                
                
                
analysis, such as gut microbiome profiling, RNA sequence analysis, or proteomic analysis Desirable Qualifications: Proficient in multi-color flow cytometry techniques Experience in cellular molecular biology
 - 
                
                
                
at the intersection of biology, and medicine? We’re seeking a talented Scientist to join our dynamic team! Our mission is to develop novel PET imaging agents for widely metastatic cancers and to develop novel
 - 
                
                
                
microscopy techniques and image analysis (confocal, multiphoton, or other advanced imaging techniques) and/or electrophysiology. Demonstrated computational knowledge, use of ImageJ, and familiarity with a
 - 
                
                
                
candidate will have (or be soon completing) a doctoral degree in biomedical engineering, chemical engineering, pharmaceutics, or a related field. The candidate must be highly motivated with evidence of
 - 
                
                
                
the progression of age-related macular degeneration. We seek a highly motivated postdoctoral fellow with experience in cell and molecular biology techniques and experience with single cell RNA sequencing. Education
 - 
                
                
                
filled. Application deadline is 12/1/2024 or until filled. Please send application materials and direct questions to: Tammy Wilgenbusch, PhD Training Director, Pediatric Psychology Licensed Psychologist
 - 
                
                
                
, biology, and medicine? We’re seeking a talented Scientist to join our dynamic team! Our mission is to develop novel PET imaging agents for widely metastatic cancers and to develop novel radioligand
 - 
                
                
                
program. There are two positions available: one with a stronger engineering development focus and a second with a stronger focus on the use of the imaging and associated subject demographics to establish
 - 
                
                
                
technology to track single GPCR molecules on cardiovascular cells derived from healthy and diseased patients. Through our collaboration with the Stanford Cardiovascular Institute, the lab has access to one